The pandemic has been hugely disruptive to supply chains and caused many clinical trials to be postponed or cancelled.
But it has also opened new fast-track pathways for potentially life-changing treatments and accelerated the trend towards digitalisation of healthcare.
To help you navigate this fast-changing landscape, we have created a series of webinars with insights from risk management specialists and insurance experts on everything from preparing for the future, helping you manage risk, building resilience into your supply chain, and ensuring that your insurance program reflects the changes.
To help you navigate this fast-changing landscape, we have created a series of webinars with insights from risk management specialists and insurance experts.”John Connolly | Life Sciences Industry Leader – North America,
Willis Towers Watson
Our first webinar took place on 2 December 2021, looking at future-proofing your life science business.
The life science sector is being transformed. Technology is reaching into every aspect of healthcare, blurring the boundaries between tech and medicine.
The revolution in gene and cell research continues to bring forward exciting new therapies.”John Connolly
Life Sciences Industry Leader – North America, Willis Towers Watson
Digitalisation has accelerated, opening up opportunities in areas such as telemedicine and home care devices.
The revolution in gene and cell research continues to bring forward exciting new therapies, while the pandemic triggered the fastest vaccine approval in history.
Within this changing landscape new risks are emerging – from supply chain vulnerabilities to increased cyber and data threats – which have left insurance markets playing catch up.
This webinar looked at these and other trends shaping the sector’s future.
During this session, our experts covered:
In case you missed it, the webnar recording can be accessed below:
We have also put together a review document providing an overview of the key talking points and learnings from the webinar, which can be downloaded from the link below:
Willis Towers Watson offers insurance-related services through its appropriately licensed and authorised companies in each country in which Willis Towers Watson operates. For further authorisation and regulatory details about our Willis Towers Watson legal entities, operating in your country, please refer to our Willis Towers Watson website. It is a regulatory requirement for us to consider our local licensing requirements.
|Future proofing your life science business